DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents
Gespeichert in:
| Veröffentlicht in: | Leukemia research 2020-07, Vol.94, p.106372-106372, Article 106372 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 106372 |
|---|---|
| container_issue | |
| container_start_page | 106372 |
| container_title | Leukemia research |
| container_volume | 94 |
| creator | Casellas Román, Heidi L. Venugopal, Kartika Feng, Yang Shabashvili, Daniil E. Posada, Luisa M. Li, Jianping Guryanova, Olga A. |
| description | |
| doi_str_mv | 10.1016/j.leukres.2020.106372 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7481860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0145212620300771</els_id><sourcerecordid>S0145212620300771</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-60efc1a80325c4736af71d9cd05d8e77e1e91dbc8cd8c02d0b12342ca865cfc83</originalsourceid><addsrcrecordid>eNqFUdtu1DAQtRCIbls-AeQfyNaXOHFeQFVvVCrw0j5b3vFk10sSR7bbav--Xm2p4ImnkWbOZWYOIZ85W3LGm7PtcsDH3xHTUjCx7zWyFe_IgutWVkpL9Z4sGK9VJbhojshxSlvGmOp495EcSVHXqqvZgsyXP3_cy3Nqh4zRZh-mRG1KAbzN6Oizzxs67nAI3tHRDn492Qk8Juo85AIpte8x4pS9HWhZZy4KZZwD3ezmMGLe7IaiO62pXRdUOiUfejsk_PRaT8jD9dX9xffq7tfN7cX5XQV10-aqYdgDt5pJoaBuZWP7lrsOHFNOY9six467FWhwGphwbMWFrAVY3SjoQcsT8vWgOz-uRnRQvKMdzBz9aOPOBOvNv5PJb8w6PJm21lw3rAiogwDEkFLE_o3LmdlHYLbmNQKzj8AcIii8L38bv7H-_LwAvh0AWM5_8hhNKh-dAJ2PCNm44P9j8QK7UJ9-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Casellas Román, Heidi L. ; Venugopal, Kartika ; Feng, Yang ; Shabashvili, Daniil E. ; Posada, Luisa M. ; Li, Jianping ; Guryanova, Olga A.</creator><creatorcontrib>Casellas Román, Heidi L. ; Venugopal, Kartika ; Feng, Yang ; Shabashvili, Daniil E. ; Posada, Luisa M. ; Li, Jianping ; Guryanova, Olga A.</creatorcontrib><identifier>ISSN: 0145-2126</identifier><identifier>EISSN: 1873-5835</identifier><identifier>DOI: 10.1016/j.leukres.2020.106372</identifier><identifier>PMID: 32445940</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>AML ; Animals ; DAC ; Decitabine ; Decitabine - pharmacology ; DNA (Cytosine-5-)-Methyltransferases - genetics ; DNA (Cytosine-5-)-Methyltransferases - metabolism ; DNA hypomethylating agents (HMA) ; DNA Methyltransferase 3A ; DNMT3A ; Leukemia, Myeloid, Acute - enzymology ; Leukemia, Myeloid, Acute - genetics ; Leukemia, Myeloid, Acute - pathology ; MDS ; Mice ; Mice, Transgenic ; Myelodysplastic Syndromes - drug therapy ; Myelodysplastic Syndromes - enzymology ; Myelodysplastic Syndromes - genetics ; Myelodysplastic Syndromes - pathology ; Neoplasm Proteins - genetics ; Neoplasm Proteins - metabolism</subject><ispartof>Leukemia research, 2020-07, Vol.94, p.106372-106372, Article 106372</ispartof><rights>2020 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-60efc1a80325c4736af71d9cd05d8e77e1e91dbc8cd8c02d0b12342ca865cfc83</citedby><cites>FETCH-LOGICAL-c467t-60efc1a80325c4736af71d9cd05d8e77e1e91dbc8cd8c02d0b12342ca865cfc83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.leukres.2020.106372$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32445940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Casellas Román, Heidi L.</creatorcontrib><creatorcontrib>Venugopal, Kartika</creatorcontrib><creatorcontrib>Feng, Yang</creatorcontrib><creatorcontrib>Shabashvili, Daniil E.</creatorcontrib><creatorcontrib>Posada, Luisa M.</creatorcontrib><creatorcontrib>Li, Jianping</creatorcontrib><creatorcontrib>Guryanova, Olga A.</creatorcontrib><title>DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents</title><title>Leukemia research</title><addtitle>Leuk Res</addtitle><subject>AML</subject><subject>Animals</subject><subject>DAC</subject><subject>Decitabine</subject><subject>Decitabine - pharmacology</subject><subject>DNA (Cytosine-5-)-Methyltransferases - genetics</subject><subject>DNA (Cytosine-5-)-Methyltransferases - metabolism</subject><subject>DNA hypomethylating agents (HMA)</subject><subject>DNA Methyltransferase 3A</subject><subject>DNMT3A</subject><subject>Leukemia, Myeloid, Acute - enzymology</subject><subject>Leukemia, Myeloid, Acute - genetics</subject><subject>Leukemia, Myeloid, Acute - pathology</subject><subject>MDS</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Myelodysplastic Syndromes - drug therapy</subject><subject>Myelodysplastic Syndromes - enzymology</subject><subject>Myelodysplastic Syndromes - genetics</subject><subject>Myelodysplastic Syndromes - pathology</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neoplasm Proteins - metabolism</subject><issn>0145-2126</issn><issn>1873-5835</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUdtu1DAQtRCIbls-AeQfyNaXOHFeQFVvVCrw0j5b3vFk10sSR7bbav--Xm2p4ImnkWbOZWYOIZ85W3LGm7PtcsDH3xHTUjCx7zWyFe_IgutWVkpL9Z4sGK9VJbhojshxSlvGmOp495EcSVHXqqvZgsyXP3_cy3Nqh4zRZh-mRG1KAbzN6Oizzxs67nAI3tHRDn492Qk8Juo85AIpte8x4pS9HWhZZy4KZZwD3ezmMGLe7IaiO62pXRdUOiUfejsk_PRaT8jD9dX9xffq7tfN7cX5XQV10-aqYdgDt5pJoaBuZWP7lrsOHFNOY9six467FWhwGphwbMWFrAVY3SjoQcsT8vWgOz-uRnRQvKMdzBz9aOPOBOvNv5PJb8w6PJm21lw3rAiogwDEkFLE_o3LmdlHYLbmNQKzj8AcIii8L38bv7H-_LwAvh0AWM5_8hhNKh-dAJ2PCNm44P9j8QK7UJ9-</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Casellas Román, Heidi L.</creator><creator>Venugopal, Kartika</creator><creator>Feng, Yang</creator><creator>Shabashvili, Daniil E.</creator><creator>Posada, Luisa M.</creator><creator>Li, Jianping</creator><creator>Guryanova, Olga A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20200701</creationdate><title>DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents</title><author>Casellas Román, Heidi L. ; Venugopal, Kartika ; Feng, Yang ; Shabashvili, Daniil E. ; Posada, Luisa M. ; Li, Jianping ; Guryanova, Olga A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-60efc1a80325c4736af71d9cd05d8e77e1e91dbc8cd8c02d0b12342ca865cfc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>AML</topic><topic>Animals</topic><topic>DAC</topic><topic>Decitabine</topic><topic>Decitabine - pharmacology</topic><topic>DNA (Cytosine-5-)-Methyltransferases - genetics</topic><topic>DNA (Cytosine-5-)-Methyltransferases - metabolism</topic><topic>DNA hypomethylating agents (HMA)</topic><topic>DNA Methyltransferase 3A</topic><topic>DNMT3A</topic><topic>Leukemia, Myeloid, Acute - enzymology</topic><topic>Leukemia, Myeloid, Acute - genetics</topic><topic>Leukemia, Myeloid, Acute - pathology</topic><topic>MDS</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Myelodysplastic Syndromes - drug therapy</topic><topic>Myelodysplastic Syndromes - enzymology</topic><topic>Myelodysplastic Syndromes - genetics</topic><topic>Myelodysplastic Syndromes - pathology</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neoplasm Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Casellas Román, Heidi L.</creatorcontrib><creatorcontrib>Venugopal, Kartika</creatorcontrib><creatorcontrib>Feng, Yang</creatorcontrib><creatorcontrib>Shabashvili, Daniil E.</creatorcontrib><creatorcontrib>Posada, Luisa M.</creatorcontrib><creatorcontrib>Li, Jianping</creatorcontrib><creatorcontrib>Guryanova, Olga A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Leukemia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Casellas Román, Heidi L.</au><au>Venugopal, Kartika</au><au>Feng, Yang</au><au>Shabashvili, Daniil E.</au><au>Posada, Luisa M.</au><au>Li, Jianping</au><au>Guryanova, Olga A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents</atitle><jtitle>Leukemia research</jtitle><addtitle>Leuk Res</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>94</volume><spage>106372</spage><epage>106372</epage><pages>106372-106372</pages><artnum>106372</artnum><issn>0145-2126</issn><eissn>1873-5835</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32445940</pmid><doi>10.1016/j.leukres.2020.106372</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0145-2126 |
| ispartof | Leukemia research, 2020-07, Vol.94, p.106372-106372, Article 106372 |
| issn | 0145-2126 1873-5835 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7481860 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | AML Animals DAC Decitabine Decitabine - pharmacology DNA (Cytosine-5-)-Methyltransferases - genetics DNA (Cytosine-5-)-Methyltransferases - metabolism DNA hypomethylating agents (HMA) DNA Methyltransferase 3A DNMT3A Leukemia, Myeloid, Acute - enzymology Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - pathology MDS Mice Mice, Transgenic Myelodysplastic Syndromes - drug therapy Myelodysplastic Syndromes - enzymology Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - pathology Neoplasm Proteins - genetics Neoplasm Proteins - metabolism |
| title | DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T02%3A24%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DNMT3A%20alterations%20associated%20with%20myeloid%20malignancies%20dictate%20differential%20responses%20to%20hypomethylating%20agents&rft.jtitle=Leukemia%20research&rft.au=Casellas%20Rom%C3%A1n,%20Heidi%20L.&rft.date=2020-07-01&rft.volume=94&rft.spage=106372&rft.epage=106372&rft.pages=106372-106372&rft.artnum=106372&rft.issn=0145-2126&rft.eissn=1873-5835&rft_id=info:doi/10.1016/j.leukres.2020.106372&rft_dat=%3Celsevier_pubme%3ES0145212620300771%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32445940&rft_els_id=S0145212620300771&rfr_iscdi=true |